Natixis Embecta Corp. Transaction History
Natixis
- $17.6 Billion
- Q3 2024
A detailed history of Natixis transactions in Embecta Corp. stock. As of the latest transaction made, Natixis holds 1 shares of EMBC stock, worth $20. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$20% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding EMBC
# of Institutions
405Shares Held
51.1MCall Options Held
162KPut Options Held
61K-
Black Rock Inc. New York, NY9.19MShares$186 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7MShares$142 Million0.0% of portfolio
-
River Road Asset Management, LLC3.48MShares$70.3 Million0.69% of portfolio
-
American Century Companies Inc Kansas City, MO3.02MShares$61.1 Million0.03% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.73MShares$55.2 Million0.72% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $1.17B
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...